Bradford Teaching Hospitals NHS Foundation Trust has unveiled its new £1.7 million da Vinci Xi robot dedicated to cancer surgery.
The new technology acts as extension of the surgeon’s hands and fingers in miniature, which enables for advanced keyhole procedures to be performed and helps eliminate potential human problems.
While using the technology, surgeons can control the device’s arms with ‘immense’ precision during minimally invasive operations – especially when surgery is taking place within a confined space where pinpoint accuracy is essential.
Within the Bradford Teaching Hospital statement, the trust highlights that robotic surgery procedures are ‘potentially less costly’ than conventional techniques as patients stay in hospital for a shorter period, and have fewer complications.
Raj Singh, Consultant Urological Surgeon, Cancer Lead, said of the new technology: “The new machine will be used for carrying out minimally invasive operations on patients with urology, bladder, kidney, and head and neck cancers.
“The da Vinci robot greatly enhances our precision as surgeons as it gives us better vision, increased control and a better working environment during the operation.
“Compared to a conventional keyhole procedures or open surgery, the da Vinci robot offers patients many potential advantages as its precision provides more accurate surgery, leads to less bleeding and fewer complications. It also provides other benefits including less pain, a shorter hospital stay and a swifter recovery period.”
Professor Mel Pickup, Chief Executive, added: “Our £1.7million investment in robotic surgery is part of a long-held commitment to ensuring that across our Trust we have the infrastructure, technology, and capability to offer the consultants that practice with us, and the patients we care for, access to the latest in innovation and the breadth and depth of treatment options to support their individual needs.”